The aim of the present study was to investigate the effect of estrogen and progesterone treatment on 5-hydroxytryptamine (serotonin)-1A (5-HT 1A ) receptor-mediated disruption of prepulse inhibition (PPI) of acoustic startle. The age-at-onset of schizophrenia is later in women than men, and it has been suggested that women may be protected from schizophrenia by the sex steroid hormone estrogen. 5-HT 1A receptors have been implicated in the development of schizophrenia and the action of antipsychotics. PPI is a model of sensorimotor gating that is deficient in schizophrenia and other illnesses. Female Sprague-Dawley rats were ovariectomized (OVX) or sham-operated. Some OVX rats received silastic implants filled with a low dose of estrogen (E20), a high dose of estrogen (E100), progesterone (P), or both the E20-and P-filled (E/P) silastic implants. Two weeks later, the rats were randomly treated with saline, or 0.02 or 0.5 mg/kg of the 5-HT 1A receptor agonist 8-hydroxy-2-dipropylaminotetralin (8-OH-DPAT). Treatment with 8-OH-DPAT resulted in a dose-dependent increase in startle amplitude in all rat groups. PPI was significantly reduced after injection of 0.5 mg/kg 8-OH-DPAT in sham-operated rats, untreated OVX rats, E20-treated OVX rats, and P-treated OVX rats. In contrast, in E100-and E/P-treated OVX rats, PPI was not significantly reduced by 0.5 mg/kg 8-OH-DPAT. These data suggest that treatment with a high dose of estrogen, or with a combination of estrogen and progesterone, prevents 8-OH-DPAT-induced disruption of PPI. Thus, these hormones could be protective against sensorimotor gating deficits, at least those induced by 5-HT 1A receptor stimulation, and may therefore be beneficial against some symptoms of schizophrenia.Schizophrenia is a severe mental illness with symptoms such as hallucinations, delusions, social withdrawal, and cognitive impairment (Harrison, 1999). Several neurotransmitters have been found to be altered in schizophrenia patients, e.g., there are changes in dopamine (D 2 and D 4 ) and 5-hydroxytryptamine (serotonin) (5-HT 1 and 5-HT 2 ) receptors (Dean, 2000). Recently, there is increasing literature on the potential importance of the 5-HT 1A receptor in schizophrenia. Post-mortem studies have revealed increased 5-HT 1A receptor density in the prefrontal cortex of patients with schizophrenia (Hashimoto et al., 1991;Simpson et al., 1996). In addition, some atypical antipsychotics, such as clozapine and ziprasidone, have a high affinity for the 5-HT 1A receptor and show a low incidence of extrapyramidal symptoms (Rollema et al., 2000).Epidemiological evidence indicates that men have an earlier onset of schizophrenia, compared with women, of approximately 3 to 4 years (Hä fner et al., 1993). This sex difference in age-at-onset is consistent across cultures and is found by many studies, regardless of the definition of onset and definition of illness used (Hä fner et al., 1993;Castle et al., 1995). Furthermore, only in women does the distribution peak for age-at-onset of schizophrenia ...